Zebrafish as an Experimental and Preclinical Model for Alzheimer’s Disease-Reference-Cited by-同舟云学术

Zebrafish as an Experimental and Preclinical Model for Alzheimer’s Disease

Published:2022-10-04 Issue:20 Volume:13 Page:2939-2941
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Bhattarai Prabesh¹,Turgutalp Bengisu²,Kizil Caghan¹²^ORCID

Affiliation:

1. Department of Neurology and The Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University Irving Medical Center, Columbia University, 650 W 168th Street, New York, New York 10032, United States

2. German Center for Neurodegenerative Diseases (DZNE) Dresden, Tatzberg 41, 01307 Dresden, Germany

Funder

Columbia University

Deutsches Zentrum f??r Neurodegenerative Erkrankungen

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.2c00583

Reference6 articles.

1. IL4/STAT6 Signaling Activates Neural Stem Cell Proliferation and Neurogenesis upon Amyloid-β42 Aggregation in Adult Zebrafish Brain

2. Single-Cell Transcriptomics Analyses of Neural Stem Cell Heterogeneity and Contextual Plasticity in a Zebrafish Brain Model of Amyloid Toxicity

3. Neuron-glia interaction through Serotonin-BDNF-NGFR axis enables regenerative neurogenesis in Alzheimer’s model of adult zebrafish brain

4. Single Cell/Nucleus Transcriptomics Comparison in Zebrafish and Humans Reveals Common and Distinct Molecular Responses to Alzheimer’s Disease

5. FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer’s disease

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ABCA7-dependent induction of neuropeptide Y is required for synaptic resilience in Alzheimer’s disease through BDNF/NGFR signaling;Cell Genomics;2024-09

2. Upgrading Mitochondria-Targeting Peptide-Based Nanocomplexes for Zebrafish In Vivo Compatibility Assays;Pharmaceutics;2024-07-20

3. Multi-target drugs for Alzheimer's disease;Trends in Pharmacological Sciences;2024-07

4. Neuroprotective effects of Shenghui decoction via inhibition of the JNK/p38 MAPK signaling pathway in an AlCl3-induced zebrafish (Danio rerio) model of Alzheimer's disease;Journal of Ethnopharmacology;2024-06

5. Alzheimer’s therapeutic development: shifting neurodegeneration to neuroregeneration;Trends in Pharmacological Sciences;2024-03